MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Wearable Sensor-Based Assessment of Lower Extremity Dystonia in X-linked Dystonia Parkinsonism

    G. Corniani, N. Landra, N. Ganza, S. Begalan, P. Acuna, C. Go, S. Baker, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

    Objective: To develop a sensor-based pipeline to identify lower limb dystonic features in X-linked dystonia parkinsonism (XDP). Background: XDP is a rare neurogenetic combined movement…
  • 2025 International Congress

    Results from the PRIME-UK Randomised Controlled Trial

    K. Lloyd, E. Tenison, C. Mcdonald, S. Haworth, C. Glover, R. Harrison, D. Pendry-Brazier, M. Smith, F. Lithander, A. Cullen, K. Naylor, N. Giles, T. Gabriel, P. Kamnerdsupaphon, A. Nodehi, Y. Ben-Shlomo, EJ. Henderson (Bristol, United Kingdom)

    Objective: To evaluate whether PRIME-Parkinson care increases the ability of people with parkinsonism (PwP) to achieve their personal goals, has a positive impact on health…
  • 2025 International Congress

    Clinical Characteristics of Sporadic Parkinson’s Disease with Negative CSF Alpha-synuclein Seed Amplification Assay

    S. Brooker, J. Pasquini, S. Choi, D. Lafontant, K. Marek, T. Simuni, P. Gonzalez-Latapi, N. Pavese, K. Poston (Chicago, USA)

    Objective: Define clinical characteristics of individuals with sporadic Parkinson’s disease (sPD) enrolled in the Parkinson’s Progression Markers Initiative (PPMI) who have a negative CSF alpha-synuclein…
  • 2025 International Congress

    Prevalence and Clinical Characteristics of Parkinson’s disease in Rural Nepal: A Community-Based Cross-Sectional Study

    A. Chandra, A. Chandra, S. Acharya (Kathmandu, Nepal)

    Objective: This study aims to determine the prevalence of PD in rural Nepal and characterize its clinical features in an effort to bridge the gap…
  • 2025 International Congress

    Investigating the Global Genetic Spectrum of Monogenic Parkinson’s Disease and Parkinsonism

    L. Lange, M. Makarious, M. Avenali, S. Bardien, M. Doquenia, C. Galandra, P. Heutink, J. Junker, Y. Kanana, I. Keller Sarmiento, K. Kumar, H. Leonard, K. Levine, SY. Lim, K. Lohmann, N. Mencacci, M. Nalls, AH. Tan, J. Trinh, EM. Valente, C. Blauwendraat, S. Bandres-Ciga, A. Singleton, ZH. Fang, C. Klein (Bethesda, USA)

    Objective: To investigate known pathogenic and risk variants linked to Parkinson’s disease (PD) at a global, multi-ancestry scale. Background: Genetic forms of PD have been…
  • 2025 International Congress

    Parkinsonism in a case of Gerstmann Sträussler Scheinker disease

    S. Poveda, O. Bernal-Pacheco, L. Lancheros, J. Montealegre (Bogotá, Colombia)

    Objective: Describe an atypical presentation of Gerstmann-Sträussler-Scheinker disease (GSS) with predominant parkinsonism due to the PRNP P102L mutation, emphasizing intrafamilial variability and diagnostic challenges in…
  • 2025 International Congress

    When post-radiotherapy parkinsonism can hide another one : A case report.

    S. Puisieux, S. Chouinard, A. Veilleux-Carpentier (Montreal, Canada)

    Objective: To describe a patient who presented with subacute and reversible post-radiotherapy parkinsonism (<2 months), allowing treatments to be weaned; and then delayed post-radiotherapy parkinsonism…
  • 2025 International Congress

    Analysis of Diagnostic Outcomes and Imaging Features in Patients with Ventriculomegaly and Gait Impairment

    C. Espinoza-Vinces, I. Avilés-Olmos, J. Núñez Córdoba, M. Jiménez Vázquez, M. Calvo Imirizaldu, G. Martí-Andrés, M. Luquin (Pamplona, Spain)

    Objective: To describe the clinical features, diagnostic outcomes, and brain MRI imaging characteristics in patients with ventriculomegaly and gait impairment Background: Emerging evidence suggests that ventriculomegaly,…
  • 2025 International Congress

    Interlaboratory cross-validation of CSF α-synuclein seeding aggregation assay for parkinsonisms

    J. Perez-Montesino, M. Fernandez, R. Ruiz-Garcia, L. Naranjo, C. Painous, A. Camara, A. Perez-Soriano, L. de Mena, Y. Compta (Barcelona, Spain)

    Objective: To evaluate CSF α-syn-SAA interlaboratory reproducibility in diagnosing Parkinson´s Disease (PD) and atypical parkinsonisms as well as interrogate the effect of changes in lot…
  • 2025 International Congress

    Atypical Parkinsonism with LRRK2 Mutation Presenting as Multiple System Atrophy

    K. Makhoul, R. Ramdhani (Great neck, USA)

    Objective: We describe a rare case of atypical parkinsonism associated with leucine-rich repeat kinase 2 (LRRK2) gene mutation presenting with clinical features suggestive of multiple…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley